Drug ApprovalsUK approves first daily pill blocking the IL-23 psoriasis signal
The MHRA has approved Icotyde for moderate to severe plaque psoriasis from age 12, after trials in which it beat placebo and an existing oral psoriasis pill.
23 October 2026
